Daniel Patrick O'Day - 10 Jun 2023 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role
Chairman & CEO, Director
Signature
/s/ Edward S. Son by Power of Attorney for Daniel P. O'Day
Issuer symbol
GILD
Transactions as of
10 Jun 2023
Net transactions value
-$266,311
Form type
4
Filing time
12 Jun 2023, 16:42:53 UTC
Previous filing
14 Mar 2023
Next filing
11 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GILD Common Stock Options Exercise +7,346 +2.8% 269,534 10 Jun 2023 Direct F1
transaction GILD Common Stock Tax liability $266,311 -3,409 -1.3% $78.12 266,125 10 Jun 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Restricted Stock Unit Options Exercise -7,346 -5.5% 125,587 10 Jun 2023 Common Stock 7,346 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2 The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.